Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
29.36
+2.23 (8.22%)
At close: Dec 5, 2025, 4:00 PM EST
29.11
-0.25 (-0.85%)
After-hours: Dec 5, 2025, 7:56 PM EST

Terns Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 10 professional analysts, the 12-month price target for Terns Pharmaceuticals stock ranges from a low of $7.44 to a high of $36. The average analyst price target of $25.59 forecasts a -12.84% decrease in the stock price over the next year.

Price Target: $25.59 (-12.84%)
Analyst Consensus: Buy
Target Low Average Median High
Price $7.44 $25.59 $33 $36
Change -74.66% -12.84% +12.40% +22.62%

Analyst Ratings

The average analyst rating for Terns Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jun '25Jul '25Aug '25Sep '25Oct '25Nov '25
Strong Buy 000013
Buy 333346
Hold 222332
Sell 000000
Strong Sell 000000
Total 5556811

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Citizens
Citizens
Buy
Maintains
$25$35
Buy Maintains $25$35 +19.21% Nov 26, 2025
Barclays
Barclays
Buy
Maintains
$28$36
Buy Maintains $28$36 +22.62% Nov 25, 2025
Truist Securities
Truist Securities
Strong Buy
Maintains
$28$35
Strong Buy Maintains $28$35 +19.21% Nov 19, 2025
BMO Capital
BMO Capital
Buy
Maintains
$22$30
Buy Maintains $22$30 +2.18% Nov 18, 2025
Mizuho
Mizuho
Buy
Maintains
$32$33
Buy Maintains $32$33 +12.40% Nov 13, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.10
from -1.12
EPS Next Year
-1.34
from -1.10
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
-1.00M-----
Revenue Growth
-------
EPS
-102.93-2.21-1.67-1.27-1.12-1.10-1.34
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1414
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027202820292030
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 202520262027202820292030
High - -
Avg - -
Low - -

EPS Forecast

EPS 202520262027202820292030
High -1.06 -1.18
Avg -1.10 -1.34
Low -1.11 -1.45

EPS Growth

EPS Growth 202520262027202820292030
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.